1 Min Read
Feb 7 (Reuters) - ALZINOVA AB:
* INITIAL RESULTS FROM PRE-STUDY WITH ALZ-101 VACCINE CONFIRM GOOD SAFETY PROFILE IN NON-HUMAN PRIMATES Source text: bit.ly/2EpNqX2 Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.